{"mainPropery":{"diseaseId":6479,"diseaseName":"GM1 gangliosidosis type 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6479/gm1-gangliosidosis-type-1","synonyms":["Gangliosidosis generalized GM1 type 1","Gangliosidosis generalized GM1 infantile form","Beta galactosidase  deficiency type 1","GLB deficiency type 1"],"synonyms-with-source":[{"name":"Gangliosidosis generalized GM1 type 1"},{"name":"Gangliosidosis generalized GM1 infantile form"},{"name":"Beta galactosidase  deficiency type 1"},{"name":"GLB deficiency type 1"}],"identifiers":[{"identifierType":"OMIM","identifierId":"230500"},{"identifierType":"ORPHANET","identifierId":"79255"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":336,"resourceName":"National Tay-Sachs and Allied Diseases Association","abbreviation":"NTSAD","address1":"2001 Beacon Street, Suite 204","address2":"","address3":"","address4":"","address5":"","city":"Boston","state":"MA","zip":"02135 ","country":"United States","phone":"","tty":"","tollFree":"800-906-8723","fax":"617-277-4463","email":"info@ntsad.org","url":"https://www.ntsad.org/","freeText":""},{"resourceID":318,"resourceName":"Hide and Seek Foundation for Lysosomal Storage Disease Research","abbreviation":"","address1":"6475 East Pacific Coast Highway","address2":"Suite 466","address3":"","address4":"","address5":"","city":"Long Beach","state":"CA","zip":"90803 ","country":"United States","phone":"","tty":"","tollFree":"(844) 762-7672","fax":"","email":"info@hideandseek.org","url":"https://hideandseek.org","freeText":""},{"resourceID":2219,"resourceName":"Alex The Leukodystrophy Charity","abbreviation":"Alex TLC","address1":"45 Peckham High Street","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":"SE15 5EB","country":"United Kingdom","phone":" 020 7701 4388","tty":"","tollFree":"","fax":"","email":"info@alextlc.org","url":"https://www.alextlc.org","freeText":""},{"resourceID":3177,"resourceName":"Cure GM1 Foundation","abbreviation":"","address1":"PO Box 6890","address2":"","address3":"","address4":"","address5":"","city":"Albany ","state":"CA","zip":"94706","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"info@curegm1.org","url":"https://curegm1.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/230500' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%22GM1%20gangliosidosis%20type%201%22%20%5Btitle%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss GM1 gangliosidosis type 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/gm1-gangliosidosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on GM1 gangliosidosis type 1. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":267,"resourceId":1104,"resourceName":"American Society of Gene & Cell Therapy -Disease treatment","descriptionText":"The <a href='https://www.asgct.org/education' target='_blank'>American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":869,"resourceId":1575,"resourceName":"RDCRN - Lysosomal Disease Network","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/ldn' target='_blank'>Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br />","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1015,"resourceId":336,"resourceName":"National Tay-Sachs and Allied Diseases Association","descriptionText":"The <a href='http://www.ntsad.org/index.php/the-diseases/gm-1 ' target='_blank'>National Tay-Sachs and Allied Diseases Association, Inc.</a> provides information about GM1 gangliosidosis. Click on the link to access this information. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1016,"resourceId":318,"resourceName":"Hide and Seek Foundation for Lysosomal Storage Disease Research","descriptionText":"The <a href='http://www.hideandseek.org/Diseases.html ' target='_blank'>Hide &amp; Seek Foundation for Lysosomal Storage Disease Research</a> provides information about GM1 gangliosidosis. Click on the link to view this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Generalized-Gangliosidoses-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/951637-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79255' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:230500' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1590,"questionText":"What is GM1 gangliosidosis?<br />","answerText":"<strong>GM1 gangliosidosis</strong> is an inherited <a href=\"http://www.ntsad.org/index.php/the-diseases/lysosomal-storage-diseases\" target=\"_blank\">lysosomal storage disorder</a> that progressively destroys nerve cells (neurons) in the brain and spinal cord. The condition may be classified into three major types based on the general age that signs and symptoms first appear: classic infantile (<a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=6479\" target=\"_blank\">type 1</a>); juvenile (<a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=10126\" target=\"_blank\">type 2</a>); and adult onset or chronic (<a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=2431\" target=\"_blank\">type 3</a>). Although the types differ in severity, their features may overlap significantly. GM1 gangliosidosis is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/GLB1\" target=\"_blank\">GLB1</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner. Treatment is currently symptomatic and supportive.[4711][10023]","dateModified":"2015-11-17T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12510,"relatedDiseaseName":"Gangliosidosis","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10891,"relatedDiseaseName":"GM1 gangliosidosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":23037,"abbreviatedInquiry":"My son has been diagnosed with GM1 gangliosidosis. Please tell me more about this condition.","caseQuestions":[{"questionId":1589,"questionText":"What are gangliosidoses?","answerText":"The gangliosidoses are a group of inherited metabolic diseases caused by a deficiency of the different proteins needed to break down fatty substances called <a href=\"http://www.ninds.nih.gov/disorders/lipid_storage_diseases/detail_lipid_storage_diseases.htm#1260114685\" target=_blank>lipids</a>. Excess lipid materials build up to harmful levels in the central and peripheral nervous systems, particularly in nerve cells. These genetically different disorders occur when both parents pass along the same mutated gene that regulates these proteins.[932] <br xmlns:w=\"urn:www.microsoft.com/word\" xmlns:st1=\"urn:www.microsoft.com/smarttags\" xmlns:o=\"urn:www.microsoft.com/office\">","dateModified":"2012-04-03T15:42:00","references":[{"referenceId":932,"authors":"","articleTitle":"NINDS Gangliosidoses Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"October 2011","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Generalized-Gangliosidoses-Information-Page","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1590,"questionText":"What is GM1 gangliosidosis?<br />","answerText":"<strong>GM1 gangliosidosis</strong> is an inherited <a href=\"http://www.ntsad.org/index.php/the-diseases/lysosomal-storage-diseases\" target=\"_blank\">lysosomal storage disorder</a> that progressively destroys nerve cells (neurons) in the brain and spinal cord. The condition may be classified into three major types based on the general age that signs and symptoms first appear: classic infantile (<a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=6479\" target=\"_blank\">type 1</a>); juvenile (<a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=10126\" target=\"_blank\">type 2</a>); and adult onset or chronic (<a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=2431\" target=\"_blank\">type 3</a>). Although the types differ in severity, their features may overlap significantly. GM1 gangliosidosis is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/GLB1\" target=\"_blank\">GLB1</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner. Treatment is currently symptomatic and supportive.[4711][10023]","dateModified":"2015-11-17T00:00:00","references":[{"referenceId":4711,"authors":"","articleTitle":"GM1 gangliosidosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/gm1-gangliosidosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10023,"authors":"Anna Caciotto, Maria Alice Donati, and Amelia Morrone","articleTitle":"GM1 Gangliosidosis","bookWebsiteJournalTitle":"Orphanet","date":"May, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=354","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1591,"questionText":"What are the signs and symptoms of GM1 gangliosidosis?<br />","answerText":"There are three general types of GM1 gangliosidosis, which differ in severity but can have considerable overlap of signs and symptoms.[4711]<br />\r\n<ul>\r\n    <li><strong>Classic infantile (type 1) GM1 gangliosidosis</strong> is the most severe type, with onset shortly after birth (usually within 6 months of age).[4711] Affected infants typically appear normal until onset, but developmental regression (loss of acquired milestones) eventually occurs.[4711] Signs and symptoms may include neurodegeneration, seizures, liver and spleen enlargement, coarsening of facial features, skeletal irregularities, joint stiffness, a distended abdomen, muscle weakness, an exaggerated startle response to sound, and problems with gait (manner of walking). About half of people with this type develop cherry-red spots in the eye. Children may become deaf and blind by one year of age.[932][933][934] Affected children typically do not live past 2 years of age.[4711]</li>\r\n    <li><strong>Juvenile (type 2) GM1 gangliosidosis</strong> is considered an intermediate form of the condition and may begin between the ages of 1 and 5. Features include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003198.htm\" target=\"_blank\">ataxia</a>, seizures, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000739.htm\" target=\"_blank\">dementia</a>, and difficulties with speech. This type progresses more slowly than type 1, but still causes decreased life expectancy (around mid-childhood or early adulthood).[4711]</li>\r\n    <li><strong>Adult (type 3) GM1 gangliosidosis</strong> may cause signs and symptoms to develop anywhere between the ages of 3 and 30. Affected people may have muscle atrophy, corneal clouding and <a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=\"_blank\">dystonia</a>.[932][933][934] Non-cancerous skin blemishes may develop on the lower part of the trunk of the body.[932] Adult GM1 is usually less severe and progresses more slowly than other forms of the condition.[932][933][934]</li>\r\n</ul>","dateModified":"2015-11-17T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":932,"authors":"","articleTitle":"NINDS Gangliosidoses Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"October 2011","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Generalized-Gangliosidoses-Information-Page","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":933,"authors":"Tegay D","articleTitle":"GM1 Gangliosidosis","bookWebsiteJournalTitle":"Medscape","date":"March 29, 2012","volume":"","pages":"","url":"http://emedicine.medscape.com/article/951637-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":934,"authors":"","articleTitle":"About Gangliosidosis-1 (GM-1)","bookWebsiteJournalTitle":"National Tay-Sachs and Allied Diseases Association, Inc.","date":"October 3, 2012","volume":"","pages":"","url":"http://www.ntsad.org/index.php/the-diseases/gm-1","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":4711,"authors":"","articleTitle":"GM1 gangliosidosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/gm1-gangliosidosis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1592,"questionText":"What causes GM1 gangliosidosis?","answerText":"All three types of GM1 gangliosidosis are caused by <a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> (changes) in the <a href=\"http://ghr.nlm.nih.gov/gene/GLB1\" target=\"_blank\"><em>GLB1</em></a> gene. This gene gives the body instructions to make an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzyme</a> called beta-galactosidase (&beta;-galactosidase), which plays an important role in the brain. The enzyme resides in compartments within cells called lysosomes, where it helps break down certain molecules, including a substance called GM1 ganglioside. GM1 ganglioside is important for nerve cell function in the brain.<br />\r\n<br />\r\nMutations in the GLB1 gene may lower or eliminate the activity of the &beta;-galactosidase enzyme, keeping GM1 ganglioside from being broken down. As a result, it accumulates to toxic levels in tissues and organs, particularly in the brain. This accumulation leads to the destruction of nerve cells, causing the features of the condition. In general, people with higher enzyme activity levels usually have milder features than those with lower activity levels.[4711]","dateModified":"2015-11-17T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":4711,"authors":"","articleTitle":"GM1 gangliosidosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"August 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/gm1-gangliosidosis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1593,"questionText":"How is GM1 gangliosidosis inherited?<br />","answerText":"GM1 gangliosidosis is a hereditary condition that is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[933][934] This means that to be affected, a person must have a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in both copies of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has:<br />\r\n<ul>\r\n    <li>a 25% (1 in 4) chance to be affected</li>\r\n    <li>a 50% (1 in 2) chance to be an unaffected carrier like each parent</li>\r\n    <li>a 25% chance to be unaffected <em>and</em> not be a carrier</li>\r\n</ul>\r\n<p>GM1 gangliosidosis is type-specific within families. This means that people with a family history of the condition are generally only at increased risk for the specific type of GM1 gangliosidosis in the family.[934]</p>","dateModified":"2015-11-17T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":933,"authors":"Tegay D","articleTitle":"GM1 Gangliosidosis","bookWebsiteJournalTitle":"Medscape","date":"March 29, 2012","volume":"","pages":"","url":"http://emedicine.medscape.com/article/951637-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":934,"authors":"","articleTitle":"About Gangliosidosis-1 (GM-1)","bookWebsiteJournalTitle":"National Tay-Sachs and Allied Diseases Association, Inc.","date":"October 3, 2012","volume":"","pages":"","url":"http://www.ntsad.org/index.php/the-diseases/gm-1","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1594,"questionText":"How might GM1 gangliosidosis be treated?<br />","answerText":"There is currently no&nbsp;effective medical treatment for&nbsp;GM1 gangliosidosis.[932][933] Symptomatic treatment for some of the neurologic signs and symptoms is available, but does not significantly alter the progression of the condition.[933][935]&nbsp;For example, anticonvulsants may initially control seizures. Supportive treatments may include proper nutrition and hydration, and keeping the affected individual's&nbsp;airway open.[932]\r\n<p><a href=\"http://www.nlm.nih.gov/medlineplus/bonemarrowtransplantation.html\" target=\"_blank\">Bone marrow transplantation</a> was reportedly&nbsp;successful in an individual with infantile/juvenile GM1 gangliosidosis; however, no long-term benefit was reported. Presymptomatic <a href=\"http://www.cancer.org/acs/groups/cid/documents/webcontent/003215-pdf.pdf\" target=\"_blank\">cord-blood hematopoietic stem-cell transplantation</a> has been advocated by some as a possible treatment due to its success in other lysosomal storage disorders.[933] Active research in the areas of enzyme replacement and <a href=\"http://ghr.nlm.nih.gov/handbook/therapy/genetherapy\" target=\"_blank\">gene therapy</a> for the condition is ongoing but has not yet&nbsp;advanced to human trials.[933][935]<br />\r\n<br />\r\nNeurologic and orthopedic sequelae may&nbsp;prevent adequate physical activity, but&nbsp;affected individuals may benefit from physical and occupational therapy.[933]</p>","dateModified":"2012-08-06T11:54:00","resourceClassificationName":"Treatment","references":[{"referenceId":932,"authors":"","articleTitle":"NINDS Gangliosidoses Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"October 2011","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Generalized-Gangliosidoses-Information-Page","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":933,"authors":"Tegay D","articleTitle":"GM1 Gangliosidosis","bookWebsiteJournalTitle":"Medscape","date":"March 29, 2012","volume":"","pages":"","url":"http://emedicine.medscape.com/article/951637-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":935,"authors":"","articleTitle":"GM1 Gangliosidosis - Infantile","bookWebsiteJournalTitle":"Hide & Seek Foundation for Lysosomal Disease Research","date":"","volume":"","pages":"","url":"http://www.hideandseek.org/Diseases.html","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":12809,"phenoTypeName":"Cherry red spot of the macula","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8980,"phenoTypeName":"Abnormal heart valve morphology","percentRanges":"-"},{"phenoTypeId":10013,"phenoTypeName":"Abnormality of the urinary system","percentRanges":"-"},{"phenoTypeId":9304,"phenoTypeName":"Angiokeratoma corporis diffusum","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10759,"phenoTypeName":"Beaking of vertebral bodies","percentRanges":"-"},{"phenoTypeId":13658,"phenoTypeName":"Cerebral degeneration","percentRanges":"-"},{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","percentRanges":"-"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","percentRanges":"-"},{"phenoTypeId":4086,"phenoTypeName":"Death in infancy","percentRanges":"-"},{"phenoTypeId":1360,"phenoTypeName":"Decreased beta-galactosidase activity","percentRanges":"-"},{"phenoTypeId":9799,"phenoTypeName":"Depressed nasal ridge","percentRanges":"-"},{"phenoTypeId":8976,"phenoTypeName":"Dilated cardiomyopathy","percentRanges":"-"},{"phenoTypeId":13394,"phenoTypeName":"Frontal bossing","percentRanges":"-"},{"phenoTypeId":14208,"phenoTypeName":"Gingival overgrowth","percentRanges":"-"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","percentRanges":"-"},{"phenoTypeId":10388,"phenoTypeName":"Hypertelorism","percentRanges":"-"},{"phenoTypeId":8278,"phenoTypeName":"Hypertrichosis","percentRanges":"-"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","percentRanges":"-"},{"phenoTypeId":14876,"phenoTypeName":"Hypoplastic vertebral bodies","percentRanges":"-"},{"phenoTypeId":6359,"phenoTypeName":"Inguinal hernia","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":5683,"phenoTypeName":"Joint stiffness","percentRanges":"-"},{"phenoTypeId":7902,"phenoTypeName":"Kyphosis","percentRanges":"-"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","percentRanges":"-"},{"phenoTypeId":13617,"phenoTypeName":"Severe short stature","percentRanges":"-"},{"phenoTypeId":10472,"phenoTypeName":"Short neck","percentRanges":"-"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","percentRanges":"-"},{"phenoTypeId":10230,"phenoTypeName":"Thickened ribs","percentRanges":"-"},{"phenoTypeId":15556,"phenoTypeName":"Vacuolated lymphocytes","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"GM1_gangliosidosis_type_1"}